02.03.2013 Views

Innovations & Investments in Healthcare - Amiando

Innovations & Investments in Healthcare - Amiando

Innovations & Investments in Healthcare - Amiando

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Moritz von Grothuss<br />

Moritz v. Grotthuss is CEO of Genlytics and responsible for all strategic, operative and<br />

adm<strong>in</strong>istrative issues of the company. Mr. v. Grotthuss co-founded Genlytics as CEO<br />

<strong>in</strong> the beg<strong>in</strong>n<strong>in</strong>g of 2012. The company successfully started to develop an <strong>in</strong>novative‚<br />

direct to the customer‘ health portal based on <strong>in</strong>dividual genetic data.<br />

Christoph He<strong>in</strong>emann<br />

Dr. Christoph He<strong>in</strong>emann is the Vice President for Strategy & Portfolio Management for the<br />

Global Diabetes Division <strong>in</strong> Sanofi. His professional experience covers the areas of Market<strong>in</strong>g,<br />

Market Access, Bus<strong>in</strong>ess Unit Management, Strategy and Bus<strong>in</strong>ess Development <strong>in</strong> Pharmaceuticals<br />

and adjacent Medtech areas. Over the recent years he has been manag<strong>in</strong>g bus<strong>in</strong>esses<br />

<strong>in</strong> the Diabetes and Cardiovascular field <strong>in</strong> Germany and with an <strong>in</strong>ternational scope.<br />

Hartwig Jaeger<br />

Dr. Hartwig Jaeger is an MD by tra<strong>in</strong><strong>in</strong>g and has worked <strong>in</strong>tensively <strong>in</strong> the healthcare<br />

area. Follow<strong>in</strong>g his basic medical tra<strong>in</strong><strong>in</strong>g at Addenbrooke‘s hospital <strong>in</strong>d Cambridge, UK,<br />

he spent six years with McK<strong>in</strong>sey as a consultant. In the last six years he has worked for<br />

both public and private hospital groups <strong>in</strong> strategic and manag<strong>in</strong>g positions where he has<br />

focussed on restructur<strong>in</strong>g, growth and hospital plann<strong>in</strong>g.<br />

Robert Jarr<strong>in</strong><br />

Robert Jarr<strong>in</strong> is a Senior Director of Government Affairs for Qualcomm. He is based <strong>in</strong><br />

Wash<strong>in</strong>gton, DC and represents Qualcomm on U.S. domestic regulatory matters relat<strong>in</strong>g<br />

to wireless health and life sciences. Jarr<strong>in</strong>’s areas of responsibility <strong>in</strong>clude wireless health<br />

policy, FDA regulatory oversight of converged medical devices, healthcare legislative affairs,<br />

CMS telehealth reimbursement and the regulation of health <strong>in</strong>formation technology.<br />

Brian David Johnson<br />

The future is Brian David Johnson‘s bus<strong>in</strong>ess. As a futurist at Intel, his charter is to develop<br />

an actionable vision for comput<strong>in</strong>g <strong>in</strong> 2020. His work is called „future cast<strong>in</strong>g“—us<strong>in</strong>g<br />

ethnographic field studies, technology research, trend data, and even science fiction to<br />

provide Intel with a pragmatic vision of consumers and comput<strong>in</strong>g.<br />

www.iihc.eu

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!